Research Library

Granulocyte-colony stimulating factor Emerging Therapy for Duchenne

Polish researchers publish new study showing highly positive results with G-CSF treatment for DMD.

Canadian Researchers Reclassify Duchenne as a Muscle Stem Cell Disease

This groundbreaking 2015 discovery explains how the understanding of the mechanism of DMD is changing, and how DMD is more closely linked to muscle stem cell missignalling than prior understanding of the disease.

G-CSF Promotes Muscle Regeneration in Duchenne

Granulocyte-colony stimulating factor, often given prior to stem cell transplants to mobilize stem cells, is now being studied as a potential low-dose long-term complentary therapy to stem cell therapy.

Stem Cell Therapy shows 97% Improvement in Duchenne Patients

This flagship study from Neurogen Brain and Spine Institute, conducted by Dr. Alok Sharma, is perhaps the most extensive stem cell study yet undertaken for Duchenne. Dr. Sharma has since succesfully treated over 400 DMD patients with stem cell therapy and is currently conducting another stem cell-DMD clinical trial.

Myoblast Stem Cell Therapy for Oculopharyngeal Muscular Dystrophy

French researchers studied the effects of autologous myyoblast stem cell therapy on 12 OPMD patients with positive functional improvements over 2 years.

Cardiac Stem Cell Therapy May Heal Heart Damage in Duchenne Muscular Dystrophy

This study examines the potential role stem cell therapy has in healing damaged heart muscles in DMD.

Skeletal Muscle-derived Stem Cell Transplants Show Promise for Duchenne

Muscle stem cells are used for DMD.

Let’s Do This!

All donations go directly to RaceMD® and support and expand our current efforts, research and therapy trials.
All of this to help deliver therapy to those who need it most.

How to Help